Feed GLAI
Summary
27 / 100 · Bulios Score
Valuation 0Growth 50Profitability 20Quality 58Debt 0Stability 27
What speaks for it
- It earns 120 USD a year on every 100 USD of invested capital.
- The price moves less than the market (beta 0.49).
What to watch
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
20212022202320242025
Diluted EPS (USD)
20212022202320242025
Revenue fell by 2.1% a year over 5 years. Over the last 3 years it grew by 6.0% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $4.08M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $40.6K
Debt $6.33M
Free cash flow over 12 months -$4.28M
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.